Yousif Capital Management, LLC Vanda Pharmaceuticals Inc. Transaction History

Yousif Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 02, 2023	SELL	$5.9 - $6.95 $7,227 - $8,513	-1,225 Reduced 3.83%	30,754 $202,000
Q1 2023 May 02, 2023	SELL	$6.18 - $7.99 $23,885 - $30,881	-3,865 Reduced 10.78%	31,979 $217,000
Q4 2022 Jan 09, 2023	SELL	$6.87 - $10.96 $69,524 - $110,915	-10,120 Reduced 22.02%	35,844 $0
Q3 2022 Nov 04, 2022	SELL	$9.44 - $11.76 $5,484 - $6,832	-581 Reduced 1.25%	45,964 $454,000
Q2 2022 Aug 01, 2022	SELL	$9.31 - $11.84 $38,776 - $49,313	-4,165 Reduced 8.21%	46,545 $507,000
Q1 2022 May 12, 2022	BUY	$10.84 - $16.55 $12,791 - $19,529	1,180 Added 2.38%	50,710 $574,000
Q4 2021 Jan 31, 2022	BUY	$15.69 - $21.14 $777,125 - $1.05 Million	49,530 New	49,530 $777,000

155

43.7M

33.8K

28.7K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $278M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of Yousif Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Yousif Capital Management, LLC with notifications on news.